RedHill Biopharma Receives Approval for COVID-19 Phase 2/3 Study with Opaganib in the UK

NEXT STORY
FDA approves Roche’s Phesgo (fixed-dose combination of Perjeta and Herceptin for subcutaneous injection) for HER2-positive breast cancer
PREV STORY
Paper Diagnostics Market To Reach USD 10.69 Billion by 2027 | Reports and Data
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

TESARO’s Mary Lynne Hedley and Lonnie Moulder Named EY National Entrepreneurs of the Year®

WALTHAM, Mass., Nov. 20, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc., an oncology-focused biopharmaceutical company, ...

author_avatar
NASDAQ Market News

Apricus Biosciences Receives Nasdaq Compliance Notice

SAN DIEGO, Dec. 01, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical ...

author_avatar
NASDAQ Market News

Advaxis to Host Research Reception at Society of Gynecologic Oncology Annual Meeting on Women’s Cancer

PRINCETON, N.J., March 02, 2017 (GLOBE NEWSWIRE) -- Advaxis, Inc. (NASDAQ:ADXS), a clinical-stage biotechnology ...

author_avatar
NASDAQ Market News